1. Vinagre J, Almeida A, Pópulo H, Batista R, Lyra J, Pinto V, Coelho R, Celestino R, Prazeres H, Lima L, Melo M, Rocha AG, Preto A, Castro P, Castro L, Pardal F, Lopes JM, Santos LL, Reis RM, Cameselle-Teijeiro J, Sobrinho-Simões M, Lima J, Máximo V, Soares P

Frequency of TERT promoter mutations in human cancers. Nature communications 4: 2185, 2013.  [Article] 

 doi: 10.1038/ncomms3185 PMID: 23887589.

 

2. Melo M, da Rocha AG, Vinagre J, Batista R, Peixoto J, Tavares C, Celestino R, Almeida A, Salgado C, Eloy C, Castro P, Prazeres H, Lima J, Amaro T, Lobo C, Martins MJ, Moura M, Cavaco B, Leite V, Cameselle-Teijeiro JM, Carrilho F, Carvalheiro M, Máximo V, Sobrinho-Simões M, Soares P

TERT Promoter Mutations Are a Major Indicator of Poor Outcome in Differentiated Thyroid Carcinomas. The Journal of clinical endocrinology and metabolism 99: E754-65, 2014.  [Article] 

 doi: 10.1210/jc.2013-3734 PMID: 24476079.

 

3. Cameselle-Teijeiro JM, Rodríguez-Pérez I, Celestino R, Eloy C, Piso-Neira M, Abdulkader-Nallib I, Soares P, Sobrinho-Simões M

Hobnail Variant of Papillary Thyroid Carcinoma: Clinicopathologic and Molecular Evidence of Progression to Undifferentiated Carcinoma in 2 Cases. The American journal of surgical pathology 41: 854-860, 2017.  [Article] 

 doi: 10.1097/PAS.0000000000000793 PMID: 28009606.

 

4. Campanella NC, Celestino R, Pestana A, Scapulatempo-Neto C, de Oliveira AT, Brito MJ, Gouveia A, Lopes JM, Guimarães DP, Soares P, Reis RM

Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs). European journal of human genetics : EJHG 23: 877-9, 2015.  [Article] 

 doi: 10.1038/ejhg.2014.195 PMID: 25248398.

 

5. Lado-Abeal J, Celestino R, Bravo SB, Garcia-Rendueles ME, de la Calzada J, Castro I, Castro P, Espadinha C, Palos F, Soares P, Alvarez CV, Sobrinho-Simões M, Cameselle-Teijeiro J

Identification of a paired box gene 8-peroxisome proliferator-activated receptor gamma (PAX8-PPARgamma) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor. Endocrine-related cancer 17: 599-610, 2010.  [Article] 

 doi: 10.1677/ERC-09-0069 PMID: 20427420.

 

6. Celestino R, Lima J, Faustino A, Vinagre J, Máximo V, Gouveia A, Soares P, Lopes JM

Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors. European journal of human genetics : EJHG 21: 503-10, 2013.  [Article] 

 doi: 10.1038/ejhg.2012.205 PMID: 22948025.

 

7. Alves JM, Lima AC, Pais IA, Amir N, Celestino R, Piras G, Monne M, Comas D, Heutink P, Chikhi L, Amorim A, Lopes AM

Reassessing the Evolutionary History of the 17q21 Inversion Polymorphism. Genome biology and evolution 7: 3239-3248, 2015.  [Article] 

 doi: 10.1093/gbe/evv214 PMID: 26560338.

 

8. Celestino R, Magalhães J, Castro P, Triller M, Vinagre J, Soares P, Sobrinho-Simões M

A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations. Histopathology 55: 482-7, 2009.  [Letter] 

 doi: 10.1111/j.1365-2559.2009.03401.x PMID: 19817905.

 

9. Boaventura P, Pereira D, Celestino R, Mendes A, Nakasawa T, Teixeira-Gomes J, Sobrinho-Simões M, Soares P

Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment. European journal of endocrinology 169: 673-679, 2013.  [Article] 

 doi: 10.1530/EJE-13-0543 PMID: 23966419.

 

10. Celestino R, Sigstad E, Løvf M, Thomassen GO, Grøholt KK, Jørgensen LH, Berner A, Castro P, Lothe RA, Bjøro T, Sobrinho-Simões M, Soares P, Skotheim RI

Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes. Genes, chromosomes & cancer 51: 1154-64, 2012.  [Article] 

 doi: 10.1002/gcc.22003 PMID: 22961909.

 

11. Camilo V, Barros R, Celestino R, Castro P, Vieira J, Teixeira MR, Carneiro F, Pinto-de-Sousa J, David L, Almeida R

Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome. BMC cancer 14: 753, 2014.  [Article] 

 doi: 10.1186/1471-2407-14-753 PMID: 25300947.

 

12. Cameselle-Teijeiro J, Pardal F, Eloy C, Ruiz-Ponte C, Celestino R, Castro P, Soares P, Sobrinho-Simões M

Follicular thyroid carcinoma with an unusual glomeruloid pattern of growth. Human pathology 39: 1540-7, 2008.  [Article] 

 doi: 10.1016/j.humpath.2008.01.014 PMID: 18602667.

 

13. Løvf M, Thomassen GO, Bakken AC, Celestino R, Fioretos T, Lind GE, Lothe RA, Skotheim RI

Fusion gene microarray reveals cancer type-specificity among fusion genes. Genes, chromosomes & cancer 50: 348-57, 2011.  [Article] 

 doi: 10.1002/gcc.20860 PMID: 21305644.

 

14. Celestino R, Nome T, Pestana A, Hoff AM, Gonçalves AP, Pereira L, Cavadas B, Eloy C, Bjøro T, Sobrinho-Simões M, Skotheim RI, Soares P

CRABP1, C1QL1 and LCN2 are biomarkers of differentiated thyroid carcinoma, and predict extrathyroidal extension. BMC cancer 18: 68, 2018.  [Article] 

 doi: 10.1186/s12885-017-3948-3 PMID: 29321030.

 

15. de Vries MM, Celestino R, Castro P, Eloy C, Máximo V, van der Wal JE, Plukker JT, Links TP, Hofstra RM, Sobrinho-Simões M, Soares P

RET/PTC rearrangement is prevalent in follicular Hürthle cell carcinomas. Histopathology 61: 833-843, 2012.  [Article] 

 doi: 10.1111/j.1365-2559.2012.04276.x PMID: 22803838.

 

16. Vinagre J, Celestino R, Gouveia A, Lima J, Faustino A, Soares P

A novel germline SDHB mutation in a GIST patient without associated paraganglioma or pheochromocytoma Virchows Archiv 459: S326-S326, 2012.  [Meeting Abstract] 

.

 

17. Polónia A, Santos L, Eloy C, Celestino R, Soares P, Jacome M, Lobo C

Sclerosing mucoepidermoid carcinoma of the thyroid in a 13 year-old female Virchows Archiv  104, 2012.  [Meeting Abstract] 

.

 

18. Vinagre J, Pinto V, Celestino R, Reis M, Pópulo H, Boaventura P, Melo M, Catarino T, Lima J, Lopes JM, Máximo V, Sobrinho-Simões M, Soares P

Telomerase promoter mutations in cancer: an emerging molecular biomarker? Virchows Archiv : an international journal of pathology 465: 119-33, 2014.  [Review] 

 doi: 10.1007/s00428-014-1608-4 PMID: 25048572.

 

19. Soares P, Celestino R, Melo M, Fonseca E, Sobrinho-Simões M

Prognostic biomarkers in thyroid cancer. Virchows Archiv : an international journal of pathology 464: 333-46, 2014.  [Review] 

 doi: 10.1007/s00428-013-1521-2 PMID: 24487783.

 

20. Cameselle-Teijeiro J, Menasce LP, Yap BK, Colaco RJ, Castro P, Celestino R, Ruíz-Ponte C, Soares P, Sobrinho-Simões M

Cribriform-morular variant of papillary thyroid carcinoma: molecular characterization of a case with neuroendocrine differentiation and aggressive behavior. American journal of clinical pathology 131: 134-42, 2009.  [Article] 

 doi: 10.1309/AJCP7ULS0VSISBEB PMID: 19095577.

 

21. Soares P, Lima J, Preto A, Castro P, Vinagre J, Celestino R, Couto JP, Prazeres H, Eloy C, Máximo V, Sobrinho-Simões M

Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas. Current genomics 12: 609-17, 2011.  [Article] 

 doi: 10.2174/138920211798120853 PMID: 22654560.

 

22. Soares P, Lima J, Preto A, Castro P, Vinagre J, Celestino R, Couto JP, Prazeres H, Eloy C, Máximo V, Sobrinho-Simões M

Alterations in Poorly Differentiated and Unddiferentiated Thyroid Carcinomas Current genomics  1, 2011.  [] 

.

 

23. Celestino R, Lima J, Faustino A, Máximo V, Gouveia A, Vinagre J, Soares P, Lopes JM

A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney-Stratakis dyad. Familial cancer 11: 189-94, 2012.  [Article] 

 doi: 10.1007/s10689-011-9499-x PMID: 22160509.

 

24. Nakazawa T, Celestino R, Machado JC, Cameselle-Teijeiro JM, Vinagre J, Eloy C, Benserai F, Lameche S, Soares P, Sobrinho-Simões M

Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features. International journal of surgical pathology 21: 379-89, 2013.  [Article] 

 doi: 10.1177/1066896912473355 PMID: 23349472.

 

25. Soares P, Celestino R, Gaspar da Rocha A, Sobrinho-Simões M

Papillary Thyroid Microcarcinoma: How to Diagnose and Manage this Epidemic? International journal of surgical pathology 22: 113-9, 2014.  [Article] 

 doi: 10.1177/1066896913517394 PMID: 24401191.

 

26. Bolfi F, Domingues MA, Sobrinho-Simões M, Soares P, Celestino R, Castilho EC, Carelli G, Paes NS, Mazeto GM

Primary squamous cell carcinoma of the thyroid diagnosed as anaplastic carcinoma: failure in fine-needle aspiration cytology? Case reports in pathology 2014: 301780, 2014.  [] 

 doi: 10.1155/2014/301780 PMID: 25295208.